Does OMAVELOXOLONE Cause Nephrolithiasis? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Nephrolithiasis have been filed in association with OMAVELOXOLONE (SKYCLARYS). This represents 1.4% of all adverse event reports for OMAVELOXOLONE.
17
Reports of Nephrolithiasis with OMAVELOXOLONE
1.4%
of all OMAVELOXOLONE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Nephrolithiasis From OMAVELOXOLONE?
Of the 17 reports, 10 (58.8%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMAVELOXOLONE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does OMAVELOXOLONE Cause?
Fatigue (118)
Nausea (101)
Hepatic enzyme increased (100)
Product dose omission issue (92)
Headache (83)
Diarrhoea (77)
Blood cholesterol increased (67)
Muscle spasms (64)
Abdominal pain upper (51)
Atrial fibrillation (48)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which OMAVELOXOLONE Alternatives Have Lower Nephrolithiasis Risk?
OMAVELOXOLONE vs OMBITASVIR
OMAVELOXOLONE vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMAVELOXOLONE vs OMEGA-3-ACID ETHYL ESTERS
OMAVELOXOLONE vs OMEGA-3-CARBOXYLIC ACIDS
OMAVELOXOLONE vs OMEGA-3 FATTY ACIDS